7.9KTreatment Views
16Answers
12.5KViews of Answers
Surgery is still a main cancer treatment option used for diagnosis, staging and even symptom relief.
As a cancer management method, it involves the physical removal of malignant tumours from the body.
For some tumours, cancer surgery may offer the best chance of cure, especially if the cancer is localised. In other cases, it may be used as a primary treatment in conjunction with other prescribed treatments.
Transanal endoscopic surgery is a method of keyhole surgery without creating a scar by using the anus as a natural orifice access. A camera and 2 small keyhole instruments can be inserted to allow the surgery to be performed. It is used to remove benign growths in the rectum that are deeper than the reach of the surgeon's finger. This is indicated for benign tumours between 7-12cm from the anus.
The CA 125 is a protein found in the blood and is often used as a tumour marker for ovarian cancer. The normal value is usually between 0 to 35 units/ml. CA 125 can be elevated in both benign and malignant conditions, so having a raised CA 125 does not mean you have cancer. In about 1% of healthy women, it is slightly elevated in the absence of disease.
Ended on November 26, 2020
Dr Ooi Wei Seong is a medical oncologist and medical director at the International Cancer Specialists, Paragon Medical. Before his current practice, Dr Ooi was with the National Cancer Centre Singapore (NCCS) and Raffles Hospital. Currently, he is also a Visiting Specialist at the NCCS. His main interest lies in lung, breast, and colon cancers.
He frequents conferences around the world to continuously update his knowledge in the latest cancer treatments.
Dr Ooi Wei Seong is a medical oncologist and medical director at the International Cancer Specialists, Paragon Medical. He graduated from Trinity College Dublin with honours distinction in 1999. After getting oncology training at St Vincent’s University Hospital in Dublin, he became a clinical fellow in oncology at Sunnybrook Odette Cancer Centre in Toronto, Canada. Upon returning to Singapore, he obtained his specialist accreditation in medical oncology.
His main interest lies in lung, breast, and colon cancers. He frequents conferences around the world to continuously update his knowledge in the latest cancer treatments. In addition to management of all solid tumours, Dr Ooi has a special interest in bone health and mechanisms of bone metastases in cancer patients.
Outside of his clinical practice, Dr Ooi is an active speaker, tutor, and researcher. He has given talks about cancer management to overseas oncologists and general practitioners around the region. In Singapore, he has spoken at GP symposiums, public forums and also conducted Cancerwise workshops. He also provided training and teachings to medical students, nurses, Duke-NUS students, and elective fellows.